YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Natco Pharma

Natco Pharma

BSE: 524816|NSE: NATCOPHARM|ISIN: INE987B01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
, 16:01
878.00
0
VOLUME 7,128
LIVE
NSE
, 16:01
879.95
0
VOLUME 172,668
News on Natco Pharma
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Natco Pharma share price falls 5% on setback in US patent litigation

1.10 pm | 20 Aug 2021 |  Source: Moneycontrol.com

Natco and partner Alvogen are reviewing the order and will evaluate all options to appeal the judgment, the pharma firm has said...

Natco faces setback in patent litigation in US for blockbuster cancer drug Imbruvica

12.42 pm | 20 Aug 2021 |  Source: Moneycontrol.com

Natco along with its partner Alvogen are reviewing the judgement and said they will evaluate all options to appeal the judgement....

Natco Pharma Standalone June 2021 Net Sales at Rs 393.80 crore, down 26.01% Y-o-Y

9.33 am | 13 Aug 2021 |  Source: Moneycontrol.com

NULL...

Hold Natco Pharma; target of Rs 1010: ICICI Direct

4.24 pm | 21 Jun 2021 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Natco Pharma with a target price of Rs 1010 in its research report dated June 18, 2021....

Natco Pharma Standalone March 2021 Net Sales at Rs 311.50 crore, down 25.85% Y-o-Y

8.33 pm | 17 Jun 2021 |  Source: Moneycontrol.com

NULL...

Natco Pharma Consolidated March 2021 Net Sales at Rs 331.30 crore, down 27.15% Y-o-Y

8.33 pm | 17 Jun 2021 |  Source: Moneycontrol.com

NULL...

1 2
Quick Links for Natco Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.